# Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD

> **NCT02652598** · PHASE2 · UNKNOWN · sponsor: **Sheppard Pratt Health System** · enrollment: 100 (estimated)

## Conditions studied

- Brain Injuries, Traumatic
- Neurocognitive Disorders
- Brain Injuries

## Interventions

- **DRUG:** Tolcapone

## Key facts

- **NCT ID:** NCT02652598
- **Lead sponsor:** Sheppard Pratt Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2020-01
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652598, "Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02652598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*